Tweets
JAKinib safety takeaways
- avoid in older population 65 yo, malignancy, CV risk, VTE risk
- appropriate in younger pts without VTE/CVD risk factors
#RNL2023 @RheumNow https://t.co/mFvvqJ9Jbp https://t.co/A76tR2S1Rb
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 2 months ago
#RNL2023 @RheumNow
Dr. Stanley Cohen: possible adverse effects of JAKi
-Herpes zoster, other infections
-Malignancy
-Occasional cytopenias
-LFTs (with DMARDs)
-Incr Cr or CPK
-Acne
-Incr lipids
-GI perf
-VTE
Which do you counsel with your patients? https://t.co/zncCw3jlK7 https://t.co/AHhDyxaumM
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 2 months ago
Dr. Stanley Cohen on JAKinibs:
Very concise and informative timeline on the multiple JAKinibs approved for multiple conditions
@RheumNow #RNL2023 https://t.co/ulLh2HikUt https://t.co/0kR8CNZvsV
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 2 months ago
How do you prevent RA in at-risk patient?
Smoking cessation! Healthy weight and exercise! Diet! Periodontal health! 🚭🏋️🥕🦷
Education follow-up!
Not robustly proven to prevent/delay RA, but may be more important than early DMARD intervention! Kevin Deane, MD
#RNL2023
Dr. John Cush @RheumNow ( View Tweet )
3 years 2 months ago
STOP-RA study on HCQ preventing RA...
HCQ did NOT prevent RA development in pre-RA pts
@RheumNow #RNL2023 https://t.co/uZRqAxWyyo https://t.co/02qUN4Hhrc
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 2 months ago
Heart to Heart: Cardiovascular Risk in RA
Tune in to hear experts discuss cardiovascular risk assessment, patient education, and the importance of disease control in the latest therapeutic update sponsored by AbbVie US Medical Affairs.
https://t.co/qfnayksf3q https://t.co/7D62APLK4Z
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 2 months ago
Full Read comprehensive revie by Isenberg on what Rx work in SLE; they review RCT data on approved drugs and Rx in development:
- Obinutuzumab
- Dapirolizumab
- Deucravacitinib
- Litifilimab
- Atacicept
- Telitacicept https://t.co/WZQ3soseDB https://t.co/UdkmFYhbGv
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 2 months ago
COMING UP NEXT! Join us May 9th for our next Tuesday Night Rheumatology. We'll be focusing on Modern Management of Psoriatic Arthritis
Remission in Psoriatic Arthritis
JAK inhibitors in Psoriasis and PsA
Pregnancy in PsA
https://t.co/8HZZAO1qIX https://t.co/UPGYXqGGu6
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 2 months ago
New download available!
RA Flares: Management and Risks
https://t.co/Ct1FXEueE2 https://t.co/7dsrJvu7hK
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 2 months ago
Tuesday Night Rheumatology: Rheumatoid Arthritis: Revolutionary Advances in Therapy
Check out this week's Tuesday Night Rheumatalogy focusing on RA.
https://t.co/oNu4XCY0ez https://t.co/Gll5Uraqwy
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 2 months ago
Watch: Year of the JAKi
https://t.co/NaZn8w1YYY https://t.co/GzhQpz8ZfM
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 2 months ago
Lupus During Pregnancy Carries Higher Maternal, Fetal Morbidity Risks
Women with SLE had higher risks for maternal and fetal morbidity compared to those without the chronic autoimmune disorder, according to a nationwide analysis of U.S. data.
https://t.co/iD4pGZPzQm https://t.co/zl9lX7i8es
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 2 months ago
